ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,042.40
-2.08%
다우존스 지수
43,428.02
-1.69%
Bitcoin
95,589.12
-2.78%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Lantern Pharma Inc (LTRN) 시세

Lantern Pharma Inc

Lantern Pharma Inc (LTRN)

NASDAQ
4.30
-0.03
(-0.69%)
종가: 22 2월 6:00AM
15분 지연
4.30
0.00
( 0.00% )
시간외 거래: 6:02AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
4.30
매수가
4.15
매도가
4.58
거래량
69,495
4.25 일간 변동폭 4.60
2.79 52주 범위 11.99
market_cap
46.374M
전일 종가
4.33
개장가
4.37
최근 거래 시간
5
@
4.58
마지막 거래 시간
07:08:14
재정 규모
US$ 302,734
VWAP
4.3562
평균 볼륨(3m)
107,311
발행 주식
10,784,725
배당수익률
-
주가수익률
-2.91
주당순이익(EPS)
-1.48
매출
-
순이익
-15.96M

Lantern Pharma Inc 정보

Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline o... Lantern Pharma Inc is a clinical-stage biotechnology company. It is focused on leveraging artificial intelligence (A.I), machine learning and genomic data to streamline the drug development process and to identify the patients that will benefit from targeted oncology therapies. The firm's pipeline of development programs involves four drug candidates and an Antibody Drug Conjugate (ADC) program directed towards eight therapeutic targets. Its A.I. platform, known as RADR, includes more than 18 billion data points, and uses big data analytics and machine learning to rapidly uncover biologically relevant genomic signatures correlated to drug response, and then identify the cancer patients that we believe may benefit most from our compounds. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
본부
Wilmington, Delaware, USA
설립됨
-
Lantern Pharma Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker LTRN. The last closing price for Lantern Pharma was US$4.33. Over the last year, Lantern Pharma shares have traded in a share price range of US$ 2.79 to US$ 11.99.

Lantern Pharma currently has 10,784,725 shares in issue. The market capitalisation of Lantern Pharma is US$46.70 million. Lantern Pharma has a price to earnings ratio (PE ratio) of -2.91.

LTRN 최신 뉴스

추가 뉴스

Form 8-K - Current report
Edgar (US Regulatory)
11 1월 2025
LTRN (-0.69%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
08 11월 2024
LTRN (-0.69%)

Form 8-K - Current report
Edgar (US Regulatory)
08 11월 2024
LTRN (-0.69%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.5-10.41666666674.85.064.152743684.60376091CS
40.071.65484633574.236.1184.151734165.06070326CS
121.10844534.73056237483.1915556.1182.951073114.46727801CS
26-0.2-4.444444444444.56.1182.79726674.16145255CS
520.317.76942355893.9911.992.791386526.16543239CS
156-2.23-34.15007656976.5311.992.38701455.74230121CS
260-10.86-71.63588390515.1624.842.38760199.24779434CS

LTRN - Frequently Asked Questions (FAQ)

What is the current Lantern Pharma share price?
The current share price of Lantern Pharma is US$ 4.30
How many Lantern Pharma shares are in issue?
Lantern Pharma has 10,784,725 shares in issue
What is the market cap of Lantern Pharma?
The market capitalisation of Lantern Pharma is USD 46.7M
What is the 1 year trading range for Lantern Pharma share price?
Lantern Pharma has traded in the range of US$ 2.79 to US$ 11.99 during the past year
What is the PE ratio of Lantern Pharma?
The price to earnings ratio of Lantern Pharma is -2.91
What is the reporting currency for Lantern Pharma?
Lantern Pharma reports financial results in USD
What is the latest annual profit for Lantern Pharma?
The latest annual profit of Lantern Pharma is USD -15.96M
What is the registered address of Lantern Pharma?
The registered address for Lantern Pharma is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
Which industry sector does Lantern Pharma operate in?
Lantern Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
RETOReTo Eco Solutions Inc
US$ 1.69
(316.36%)
22.86M
GSUNGolden Sun Health Technology Group Ltd
US$ 4.19
(58.11%)
592.97k
CNEYCN Energy Group Inc
US$ 0.3185
(30.21%)
10.2M
ORISOriental Rise Holdings Ltd
US$ 1.42
(26.79%)
690.77k
CCTGCCSC Technology International Holdings Ltd
US$ 2.13
(25.29%)
35.84k
BOXLBoxlight Corporation
US$ 2.57
(-17.10%)
535.74k
BOWNBowen Acquisition Corporation
US$ 3.2799
(-13.23%)
1.13k
NKLANikola Corporation
US$ 0.3315
(-12.76%)
2.77M
CHSNChanson International Holding
US$ 0.321
(-12.39%)
7.08M
BMRABiomerica Inc
US$ 0.7601
(-9.40%)
38.47k
RETOReTo Eco Solutions Inc
US$ 1.69
(316.36%)
22.86M
CNEYCN Energy Group Inc
US$ 0.3185
(30.21%)
10.2M
ADTXAditxt Inc
US$ 0.091
(-0.55%)
8.63M
DGLYDigital Ally Inc
US$ 0.0836
(1.33%)
7.47M
MLGOMicroAlgo Inc
US$ 5.90
(-7.23%)
7.16M

LTRN Discussion

게시물 보기
Monksdream Monksdream 6 월 전
LTRN under $5
👍️0
anabu9 anabu9 6 월 전
Finally an UP day. 'hope institutions will see this nugget soon
👍️0
FALCON1 FALCON1 7 월 전
https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri
https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
👍️0
dinogreeves dinogreeves 10 월 전
Nice drop
🕳️ 1 🪦 1 ⚰️ 1
Monksdream Monksdream 10 월 전
LTRN under $10
👍️0
Monksdream Monksdream 11 월 전
Early Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?orderBy=percentChange&orderDir=desc
👍️0
dinogreeves dinogreeves 11 월 전
Monk, take a look at ANV*S. Data is due sometime in April, Parkinsons and Alzheimers. They just did a private placement on Friday and another one today to an institutional investor. "Subject to Certain Conditions". Looks like April is go time.
👍️0
dinogreeves dinogreeves 11 월 전
I think we can revisit the high again hopefully this week. Been here since 7.20
🖕🏻 1
spartex spartex 11 월 전
10-K filing, Earnings Webcast, Presentation in link below from LTRN company website


https://ir.lanternpharma.com/news-events/press-releases/detail/150/lantern-pharma-reports-fourth-quarter-fiscal-year-2023
👍️0
Monksdream Monksdream 11 월 전
LTRN new 52 hi
👍️0
dinogreeves dinogreeves 11 월 전
Another very good day today.
👍️0
Monksdream Monksdream 11 월 전
LTRN 10Q due 3/18
👍️0
dinogreeves dinogreeves 11 월 전
Very good move on Friday.
🪦 1 ☠️ 1 ⚰️ 1 ⚱️ 1
dinogreeves dinogreeves 11 월 전
This company will see 3 digit dollars, how soon? All depends on just one science behind their Artificial Intelligence to decode one cancer indication the rest will be history.
👍️0
dinogreeves dinogreeves 11 월 전
This is going to have one heck of a run.
👍️0
Tremors! Tremors! 11 월 전
Will they break 10.00!??
👍️0
Roily23 Roily23 12 월 전
👍️0
Roily23 Roily23 12 월 전
AI is the next .com and AI's application in medicine and pharma will be a game changer.

Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. It develops LP-100 for treatment in combination with the class of anticancer agent known as PARP inhibitors. The company also develops LP-300 as a combination therapy for never-smokers with non-small cell lung cancer adenocarcinoma; and LP-284, a novel small molecule and DNA damaging agent for the treatment of mantle cell lymphoma and double hit lymphoma. In addition, it offers LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers or that harbor mutations in DNA repair pathways. Further, the company operates ADC program, an antibody drug conjugate therapeutic approach for cancer treatment. Additionally, the company's artificial intelligence platform RADR uses big data analytics and machine learning for combining molecular data. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
👍️0

최근 히스토리

NASDAQ
LTRN
Lantern Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지